Evidence map›Paper›PMID 28545060›Full record

ArticlePloS one2017

SiGNet: A signaling network data simulator to enable signaling network inference.

Elizabeth A Coker, Costas Mitsopoulos, Paul Workman, Bissan Al-Lazikani

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth A CokerCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.
Costas MitsopoulosCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.
Paul WorkmanCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.
Bissan Al-LazikaniCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.

Funding

Cancer Research UK 11566Cancer Research UK 22897Cancer Research UK 23187
6 · The paper itself

Abstract

Network models are widely used to describe complex signaling systems. Cellular wiring varies in different cellular contexts and numerous inference techniques have been developed to infer the structure of a network from experimental data of the network's behavior. To objectively identify which inference strategy is best suited to a specific network, a gold standard network and dataset are required. However, suitable datasets for benchmarking are difficult to find. Numerous tools exist that can simulate data for transcriptional networks, but these are of limited use for the study of signaling networks. Here, we describe SiGNet (Signal Generator for Networks): a Cytoscape app that simulates experimental data for a signaling network of known structure. SiGNet has been developed and tested against published experimental data, incorporating information on network architecture, and the directionality and strength of interactions to create biological data in silico. SiGNet is the first tool to simulate biological signaling data, enabling an accurate and systematic assessment of inference strategies. SiGNet can also be used to produce preliminary models of key biological pathways following perturbation.

Indexed as

User-Computer InterfaceGene Regulatory NetworksInternetProteinsSignal TransductionProteins

Identifiers

PMID28545060
PMCPMC5435248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.